Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXTENZA Upper vs Lower Canaliculus in Cataract Surgery
NCT04592081Phase 4Unknown
- Start
- Aug 2020
- Primary completion
- Feb 2021
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ozurdex in ocular inflammation and post-surgical ocular pain (2 arms). Primary endpoints: Post-operative inflammation scores at Day 30 and Post-op pain scores at Day 30. Status: unknown.
02
Drugs
ozurdex
03
Conditions
ocular inflammationpost-surgical ocular pain
Beyond the preview
Go deeper on NCT04592081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04592081.